Skip to content
About
Technology
News
Menu
About
Technology
News
Contact
Bound Therapeutics | News | Bound Therapeutics formed strategic alliance with Bio-Synthesis, Inc. to jointly develop bridged nucleic acid (BNA)-based RNA therapeutics
Bound Therapeutics formed strategic alliance with Bio-Synthesis, Inc. to jointly develop bridged nucleic acid (BNA)-based RNA therapeutics
October 30, 2017
Written by
Original Source
Contact
info@boundtherapeutics.com
Share it
Others Press Release
June 14, 2019
RNA Blockade to Treat Triple Negative Breast Cancer
News
September 10, 2018
Bound Therapeutics is selected as a finalist in the UC Science Center QED proof-of-concept program
News
October 30, 2017
Bound Therapeutics formed strategic alliance with Bio-Synthesis, Inc. to jointly develop bridged nucleic acid (BNA)-based RNA therapeutics
News
